Food and Drug Administration. (2023). Cyfendus.
This webpage contains information on Cyfendus, a two-dose anthrax vaccine approved by FDA in 2023 for use after suspected or confirmed exposure to anthrax.
Rate: Favorite:
You must Login to add a comment
  • This item doesn't have any comments

Enter your email address to receive important announcements and updates through the ASPR TRACIE Listserv.